ZA200203444B - Substituted indole mannich bases. - Google Patents
Substituted indole mannich bases.Info
- Publication number
- ZA200203444B ZA200203444B ZA200203444A ZA200203444A ZA200203444B ZA 200203444 B ZA200203444 B ZA 200203444B ZA 200203444 A ZA200203444 A ZA 200203444A ZA 200203444 A ZA200203444 A ZA 200203444A ZA 200203444 B ZA200203444 B ZA 200203444B
- Authority
- ZA
- South Africa
- Prior art keywords
- substituted indole
- mannich bases
- indole mannich
- bases
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19963178A DE19963178A1 (de) | 1999-12-27 | 1999-12-27 | Substituierte Indol-Mannichbasen |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200203444B true ZA200203444B (en) | 2003-06-25 |
Family
ID=7934622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200203444A ZA200203444B (en) | 1999-12-27 | 2002-04-30 | Substituted indole mannich bases. |
Country Status (29)
Country | Link |
---|---|
US (1) | US7091220B2 (no) |
EP (1) | EP1261585B1 (no) |
JP (1) | JP2003519124A (no) |
KR (1) | KR20020062314A (no) |
CN (1) | CN1219763C (no) |
AR (2) | AR027059A1 (no) |
AT (1) | ATE374184T1 (no) |
AU (1) | AU782585B2 (no) |
BR (1) | BR0016747A (no) |
CA (1) | CA2392866A1 (no) |
CO (1) | CO5251383A1 (no) |
CY (1) | CY1107080T1 (no) |
CZ (1) | CZ20021708A3 (no) |
DE (2) | DE19963178A1 (no) |
DK (1) | DK1261585T3 (no) |
ES (1) | ES2293935T3 (no) |
HK (1) | HK1051367A1 (no) |
HU (1) | HUP0203873A3 (no) |
IL (1) | IL149426A0 (no) |
NO (1) | NO20022803D0 (no) |
NZ (1) | NZ518876A (no) |
PE (1) | PE20010993A1 (no) |
PL (1) | PL355446A1 (no) |
PT (1) | PT1261585E (no) |
RU (1) | RU2265594C2 (no) |
SK (1) | SK8522002A3 (no) |
UY (1) | UY26511A1 (no) |
WO (1) | WO2001047885A1 (no) |
ZA (1) | ZA200203444B (no) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI224101B (en) * | 2001-06-20 | 2004-11-21 | Wyeth Corp | Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
JP4399253B2 (ja) * | 2001-06-20 | 2010-01-13 | ワイス | プラスミノゲンアクチベーターインヒビター−1(pai−1)のインヒビターとしての、置換されたインドール酸誘導体 |
US7005445B2 (en) | 2001-10-22 | 2006-02-28 | The Research Foundation Of State University Of New York | Protein kinase and phosphatase inhibitors and methods for designing them |
DE10153346A1 (de) * | 2001-10-29 | 2004-04-22 | Grünenthal GmbH | Substituierte Indole |
ATE331708T1 (de) * | 2002-12-10 | 2006-07-15 | Wyeth Corp | Substituierte 3-alkyl- und 3-arylalkyl-1h-indol-1-yl-essigsäure-derivate als plasminogen aktivator inhibitor-1 (pai-1) inhibitoren |
BR0316574A (pt) * | 2002-12-10 | 2005-10-04 | Wyeth Corp | Derivados de ácido acético 3-carbonil-1h-indol-1-il substituìdo como inibidores do inibidor-1 do ativador do plasminogênio (pai-1) |
UA80453C2 (en) * | 2002-12-10 | 2007-09-25 | Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1) | |
CN1726191A (zh) * | 2002-12-10 | 2006-01-25 | 惠氏公司 | 用作纤溶酶原激活物抑制剂-1(pai-1)的抑制剂的取代的吲哚氧代-乙酰氨基乙酸衍生物 |
ES2314289T3 (es) * | 2002-12-10 | 2009-03-16 | Wyeth | Derivados del acido 1h-indol-3-il glioxilico sustituidos con arilo, ariloxi y alquloxi como inhibidores del inhibidor del activador del plasminogeno-1(pai-1). |
US7268159B2 (en) | 2003-09-25 | 2007-09-11 | Wyeth | Substituted indoles |
US7420083B2 (en) | 2003-09-25 | 2008-09-02 | Wyeth | Substituted aryloximes |
US7442805B2 (en) * | 2003-09-25 | 2008-10-28 | Wyeth | Substituted sulfonamide-indoles |
US7534894B2 (en) * | 2003-09-25 | 2009-05-19 | Wyeth | Biphenyloxy-acids |
US7141592B2 (en) * | 2003-09-25 | 2006-11-28 | Wyeth | Substituted oxadiazolidinediones |
US7446201B2 (en) * | 2003-09-25 | 2008-11-04 | Wyeth | Substituted heteroaryl benzofuran acids |
US7351726B2 (en) * | 2003-09-25 | 2008-04-01 | Wyeth | Substituted oxadiazolidinediones |
US7411083B2 (en) | 2003-09-25 | 2008-08-12 | Wyeth | Substituted acetic acid derivatives |
US7265148B2 (en) | 2003-09-25 | 2007-09-04 | Wyeth | Substituted pyrrole-indoles |
US7342039B2 (en) * | 2003-09-25 | 2008-03-11 | Wyeth | Substituted indole oximes |
US7582773B2 (en) * | 2003-09-25 | 2009-09-01 | Wyeth | Substituted phenyl indoles |
US7163954B2 (en) * | 2003-09-25 | 2007-01-16 | Wyeth | Substituted naphthyl benzothiophene acids |
US7332521B2 (en) | 2003-09-25 | 2008-02-19 | Wyeth | Substituted indoles |
KR20070045353A (ko) * | 2004-08-23 | 2007-05-02 | 와이어쓰 | 플라스미노겐 활성화제 억제제-1의 억제제로서티아졸로-나프틸 산 |
CN101044136A (zh) * | 2004-08-23 | 2007-09-26 | 惠氏公司 | 作为pai-1抑制剂的吡咯基-萘基酸 |
AU2005277138A1 (en) * | 2004-08-23 | 2006-03-02 | Wyeth Holdings Corporation | Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (PAI-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
BRPI0614340A2 (pt) | 2005-08-17 | 2011-04-12 | Wyeth Corp | indóis substituìdos e métodos de seu uso |
US7838542B2 (en) | 2006-06-29 | 2010-11-23 | Kinex Pharmaceuticals, Llc | Bicyclic compositions and methods for modulating a kinase cascade |
DE102006033109A1 (de) * | 2006-07-18 | 2008-01-31 | Grünenthal GmbH | Substituierte Heteroaryl-Derivate |
CN102686635B (zh) * | 2009-05-01 | 2014-10-22 | 汉高公司 | 用于厌氧可固化组合物的固化促进剂 |
WO2013032960A2 (en) * | 2011-08-26 | 2013-03-07 | Uwm Research Foundation, Inc. | Vitamin d receptor - coregulator inhibitors |
CN102687719A (zh) * | 2012-06-04 | 2012-09-26 | 陕西海安实业有限责任公司 | 一种新型高效油田用杀菌剂及其制备方法 |
US20170174825A1 (en) * | 2014-03-18 | 2017-06-22 | The Board Of Regents For Oklahoma State University | Systems and methods for production of artificial eumelanin |
KR20180046531A (ko) | 2016-10-28 | 2018-05-09 | 주식회사 대웅제약 | 3-아미노알킬레이티드 인돌 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3296072A (en) * | 1962-06-11 | 1967-01-03 | Upjohn Co | Method of treating mental depression |
FR2181559A1 (en) | 1972-04-28 | 1973-12-07 | Aec Chimie Organique Bio | N-Phenylalkyl-N-3-indolylalkyl-alkylamines - with sedative, neuroleptic, analgesic, hypotensive, antiserotonin, adrenolytic activity |
GB1374414A (en) | 1972-06-12 | 1974-11-20 | Sterling Drug Inc | 1-acyl-3-amino-alkyl-indoles and their preparation |
GB1456208A (en) * | 1972-12-28 | 1976-11-24 | Agfa Gevaert | Thermographic processes and recording material for use therein |
DE2724809A1 (de) | 1977-06-02 | 1978-08-31 | Dieter P Philippen | Urinflaschen-spuelgeraet |
US4341402A (en) * | 1980-03-06 | 1982-07-27 | Sterling Drug Inc. | Systems employing indole color formers |
DE3209305A1 (de) | 1982-03-15 | 1983-09-22 | SIC AG, 4020 Basel | Verfahren zur automatischen entleerung und reinigung von hygienegefaessen unter optimaler zufuehrung des spuelwassers bei minimalem wasserverbrauch |
DE3542698A1 (de) * | 1984-12-04 | 1986-06-05 | Glaxo Group Ltd., London | Indolderivate, verfahren zu ihrer herstellung und sie enthaltende, pharmazeutische zubereitungen |
SE449483B (sv) | 1986-03-12 | 1987-05-04 | Juhani Jervinen | Anordning for att avlegsna urin fran en flexibel urinuppsamlingspase |
US4855448A (en) | 1986-08-26 | 1989-08-08 | A. H. Robins Company, Incorporated | 2-Amino-3-aroyl-γ-oxobenzenebutanoic acids and esters |
GB9226532D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
GB9226537D0 (en) | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
CA2130294A1 (en) | 1994-08-17 | 1996-02-18 | F. W. Arthur Morrow | Method of cleaning an ostomy pouch |
JPH11513666A (ja) | 1995-10-10 | 1999-11-24 | イーライ・リリー・アンド・カンパニー | N−[2−置換−3−(2−アミノエチル)−1h−インドール−5−イル]−アミド:新規5−ht▲下1f▼作動剤 |
US5735301A (en) | 1996-02-22 | 1998-04-07 | Rower; Gary | Urostomy patient equipment irrigation system |
NZ506329A (en) | 1998-02-25 | 2004-01-30 | Inst Genetics Llc | Inhibitors of phospholipase enzymes |
DE19823326A1 (de) | 1998-05-26 | 1999-12-02 | Volker Fesser | Einrichtung zum Entleeren und Desinfizieren von Urin- und Sekretbeuteln |
DE19963177A1 (de) * | 1999-12-27 | 2001-07-12 | Gruenenthal Gmbh | Substanzbibliothek |
US6263887B1 (en) | 2000-01-14 | 2001-07-24 | Dornoch Medical Systems, Inc. | Liquid waste disposal and canister flushing system and method |
-
1999
- 1999-12-27 DE DE19963178A patent/DE19963178A1/de not_active Ceased
-
2000
- 2000-12-20 IL IL14942600A patent/IL149426A0/xx unknown
- 2000-12-20 JP JP2001549357A patent/JP2003519124A/ja not_active Withdrawn
- 2000-12-20 AU AU31610/01A patent/AU782585B2/en not_active Ceased
- 2000-12-20 ES ES00991219T patent/ES2293935T3/es not_active Expired - Lifetime
- 2000-12-20 BR BR0016747-9A patent/BR0016747A/pt not_active IP Right Cessation
- 2000-12-20 RU RU2002120478/04A patent/RU2265594C2/ru not_active IP Right Cessation
- 2000-12-20 DK DK00991219T patent/DK1261585T3/da active
- 2000-12-20 CN CNB008177317A patent/CN1219763C/zh not_active Expired - Fee Related
- 2000-12-20 WO PCT/EP2000/012974 patent/WO2001047885A1/de active Search and Examination
- 2000-12-20 US US10/168,985 patent/US7091220B2/en not_active Expired - Fee Related
- 2000-12-20 CZ CZ20021708A patent/CZ20021708A3/cs unknown
- 2000-12-20 DE DE50014679T patent/DE50014679D1/de not_active Expired - Lifetime
- 2000-12-20 PL PL00355446A patent/PL355446A1/xx not_active Application Discontinuation
- 2000-12-20 KR KR1020027007032A patent/KR20020062314A/ko not_active Application Discontinuation
- 2000-12-20 SK SK852-2002A patent/SK8522002A3/sk unknown
- 2000-12-20 CA CA002392866A patent/CA2392866A1/en not_active Abandoned
- 2000-12-20 HU HU0203873A patent/HUP0203873A3/hu unknown
- 2000-12-20 NZ NZ518876A patent/NZ518876A/en unknown
- 2000-12-20 AT AT00991219T patent/ATE374184T1/de active
- 2000-12-20 PT PT00991219T patent/PT1261585E/pt unknown
- 2000-12-20 EP EP00991219A patent/EP1261585B1/de not_active Expired - Lifetime
- 2000-12-21 AR ARP000106840A patent/AR027059A1/es not_active Application Discontinuation
- 2000-12-21 AR ARP000106841A patent/AR027060A1/es unknown
- 2000-12-22 CO CO00097385A patent/CO5251383A1/es not_active Application Discontinuation
- 2000-12-26 PE PE2000001397A patent/PE20010993A1/es not_active Application Discontinuation
- 2000-12-27 UY UY26511A patent/UY26511A1/es not_active Application Discontinuation
-
2002
- 2002-04-30 ZA ZA200203444A patent/ZA200203444B/xx unknown
- 2002-06-12 NO NO20022803A patent/NO20022803D0/no not_active Application Discontinuation
-
2003
- 2003-05-22 HK HK03103625A patent/HK1051367A1/xx not_active IP Right Cessation
-
2007
- 2007-12-10 CY CY20071101569T patent/CY1107080T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200203444B (en) | Substituted indole mannich bases. | |
ZA200000894B (en) | 4-Phenyl-pyridine derivatives. | |
ZA200201055B (en) | Amino-triazolopyridine derivatives. | |
HK1051037A1 (en) | Benzodiazepine derivatives. | |
MXPA02005101A (es) | Derivados de indol canabimimeticos. | |
ZA988078B (en) | Substituted oxindole derivatives. | |
ZA200202544B (en) | Benzodiazepine derivatives. | |
ZA200203581B (en) | Bicyclic imidazo-3-yl-amine derivatives. | |
HK1046411A1 (en) | 5-Phenyl-pyrimidine derivatives. | |
HK1051863A1 (en) | Indol-3-yl derivatives. | |
EP1187607A4 (en) | indole compounds | |
HK1037619A1 (en) | Indole derivatives. | |
MXPA01012041A (es) | Derivados de indol. | |
ZA200110053B (en) | Factor via inhibitors. | |
HK1049161A1 (en) | Indole derivatives. | |
ZA200108913B (en) | Imidazodiazepine derivative. | |
MXPA00011504A (es) | Derivados heterociclicos sustituidos. | |
IL150336A0 (en) | Novel indole derivatives | |
ZA200201276B (en) | 3-Amino-2-phenyl-propane derivatives. | |
EP1226140A4 (en) | NEW INDOLIC COMPOUNDS | |
PT1246799E (pt) | Bases de mannich de pirrol substituidas | |
HK1054382A1 (en) | Substituted pyrroles. | |
MXPA01011285A (es) | Derivados de tio-oxindol. | |
EP1187608A4 (en) | INDOLE-BASED COMPOUNDS | |
SI1261585T1 (sl) | Substituirane indol-Mannichove baze |